Posted inBiotechnology
In-Sensor Cryptography Links Physical Process to Digital Identity
In an era where the authenticity of digital content is increasingly called into question, a groundbreaking development promises to redefine…
Posted inGenetics
Epigenetic Memory from Inflammation May Prime the Gut for Colon Cancer
Epigenetics marks [KATERYNA KON / Science Photo Library / Getty Images] It is well known that chronic inflammation can increase…
Posted inGenetics
Scout-Triggered Proteomics Sharpens HCP Control
Host-cell proteins (HCPs) remain one of bioprocessing’s most stubborn analytical headaches. These residual impurities, shed by production cells during manufacturing,…
Posted inGenetics
Biopharma Benefitting from AI in Manufacturing
Biopharma is embracing artificial intelligence (AI), according to the European industry group, IFMPA, which points to process development and visual…
Posted inGenetics
The Three Pillars of Successful AI Deployments
Artificial intelligence and machine learning (AI/ML) are breakthrough tools in biopharmaceutical processing, but they are only as good as the…
Posted inGenetics
Rentschler Highlights Milford Site Progress and Growth
Rentschler’s newest production line at its Milford, MA, site became fully operational two years ago. [Rentschler Biopharma] During a gathering…
Posted inGenetics
Xaira’s First Virtual Cell Model Is Largest To-Date, Toward Complex Biology
Credit: urfinguss / iStock / Getty Images Plus Billion dollar-backed AI drug developer, Xaira Therapeutics, has recently released the largest virtual cell model to-date to predict how…
Posted inBiotechnology
Scaling Radioligand Therapy: Expanding the Impact of Theranostics
By Renaud Dehareng, Chief Executive Officer, CuriumRadioligand therapy has irrevocably changed oncology, proving we can map biology and strike cancer…
Posted inBiotechnology
After ph. 2 readout, analysts herald ‘best-in-class potential’ for Maze kidney candidate as stock plummets
Maze Therapeutics has revealed topline phase 2 data for its lead kidney disease candidate that has analysts heralding its “best-in-class…
Posted inMedical Technology
Endogenex nets $50M to carry intestinal diabetes procedure to the FDA
Endogenex has raised $50 million in venture capital financing to complete the development of its minimally invasive procedure for Type…